BioNano Genomics (BNGO) Gets a Hold From Maxim Group
TipRanksMar 9 11:15 ET
Bionano Genomics Analyst Ratings
BenzingaMar 7 08:41 ET
A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk
TipRanksMar 7 01:01 ET
Analysts Are Bullish on Top Healthcare Stocks: BioNano Genomics (BNGO), Legend Biotech (LEGN)
TipRanksFeb 2 07:31 ET
Maxim Group Remains a Hold on BioNano Genomics (BNGO)
TipRanksJan 25 13:35 ET
BioNano Genomics (BNGO) Gets a Buy From BTIG
TipRanksJan 7 05:28 ET
BTIG Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
TipRanksDec 31, 2023 05:07 ET
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and Ascendis Pharma (ASND)
TipRanksNov 16, 2023 06:10 ET
Bionano Genomics Analyst Ratings
BenzingaNov 13, 2023 07:50 ET
Scotiabank Remains a Buy on BioNano Genomics (BNGO)
TipRanksNov 10, 2023 07:38 ET
Maxim Group Adjusts Bionano Genomics Price Target to $6 From $30, Maintains Buy Rating
MT NewswiresOct 18, 2023 12:52 ET
Bionano Genomics Analyst Ratings
BenzingaAug 10, 2023 15:40 ET
BTIG Remains a Buy on BioNano Genomics (BNGO)
TipRanksJul 28, 2023 06:05 ET
BTIG Adjusts Price Target on Bionano Genomics to $2 From $3, Maintains Buy Rating
MT NewswiresMay 18, 2023 10:49 ET
BTIG Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
TipRanksMay 18, 2023 06:15 ET
BioNano Genomics (BNGO) Receives a Buy From Maxim Group
TipRanksMar 14, 2023 08:19 ET
Analysts' Top Healthcare Picks: Outlook Therapeutics (OTLK), BioNano Genomics (BNGO)
TipRanksMar 14, 2023 00:24 ET
Maxim Group Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
TipRanksMar 4, 2023 15:06 ET
Oppenheimer Adjusts Bionano Genomics' Price Target to $9 From $12, Maintains Outperform Rating
MT NewswiresFeb 6, 2023 09:13 ET
Oppenheimer Maintains Outperform on Bionano Genomics, Lowers Price Target to $9
Benzinga Real-time NewsFeb 6, 2023 07:38 ET
No Data
No Data